Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19913365 | 0.86 | GRM1 (0.41) | GRM1FFAR3 | |
| SCHEMBL19757727 | 0.86 | FFAR3 (0.36) | GRM1FFAR3 | |
| SCHEMBL478303 | 0.80 | GRM1 (0.40) | GRM1FFAR3 | |
| SCHEMBL21954700 | 0.76 | — | — | |
| SCHEMBL16933182 | 0.74 | GRM1 (0.40) | GRM1FFAR3 | |
| SCHEMBL16892283 | 0.73 | FFAR3 (0.38) | GRM1FFAR3 | |
| SCHEMBL23904374 | 0.73 | GRM1 (0.43) | GRM1FFAR3 | |
| SCHEMBL10151921 | 0.72 | GRM1 (0.36) | GRM1FFAR3 | |
| SCHEMBL16185854 | 0.71 | — | — | |
| SCHEMBL15114105 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10919937-B2 | Bicyclic peptide ligands and uses thereof | BICYCLETX LIMITED (GB) | 2021-02-16 | — | — | US | disclosed |
| US-20200131228-A1 | BICYCLIC PEPTIDE LIGANDS AND USES THEREOF | BICYCLETX LIMITED (GB) | 2020-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200131228-A1 | BICYCLIC PEPTIDE LIGANDS AND USES THEREOF | VIP, NGLY1, BID | GRM1 1648/4885FFAR3 560/4885 |
| US-10919937-B2 | Bicyclic peptide ligands and uses thereof | VIP, NGLY1, BID | GRM1 1648/4885FFAR3 560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.